ak 295 has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Culver, DG; Davis, AA; Glass, JD; Powers, JC; Wang, MS; Wang, Q | 1 |
| Bartus, RT; Chen, EY; Kordower, JH; Lynch, G | 1 |
2 other study(ies) available for ak 295 and Nerve Degeneration
| Article | Year |
|---|---|
Calpain inhibition protects against Taxol-induced sensory neuropathy.
Topics: Animals; Antineoplastic Agents; Axons; Calpain; Caspases; Cell Death; Cell Line; Cells, Cultured; Dipeptides; Electrophysiology; Female; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microtubules; Nerve Degeneration; Neurons, Afferent; Paclitaxel; Rats; Rats, Inbred Strains | 2004 |
Cortical ablation induces a spreading calcium-dependent, secondary pathogenesis which can be reduced by inhibiting calpain.
Topics: Animals; Antibodies; Calcium; Calpain; Cerebral Cortex; Cysteine Proteinase Inhibitors; Dipeptides; Geniculate Bodies; Immunohistochemistry; Male; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Spectrin; Visual Cortex | 1999 |